Doctors Misdiagnose Rare Inflammatory Disease in Girl, Leading to Years of Uncertainty
Translated & summarized from N12 by baba
A young girl, initially told her skin spots were sunspots, was eventually diagnosed with morphea, a rare inflammatory disease, after years of uncertainty. The condition can affect skin, muscles, and bones, potentially causing growth impairments in children. Doctors at Schneider Children's Medical Center successfully treated her with steroids and immunosuppressants, rendering the disease inactive. Early diagnosis and treatment are crucial to prevent irreversible damage, though most children with morphea live active lives.
The story in 5 lines · by baba
- A girl initially diagnosed with sunspots was later found to have morphea, a rare inflammatory skin disease.
- Morphea can cause skin hardening and affect muscles and bones, potentially leading to growth issues in children.
- Years passed between the first appearance of symptoms and the correct diagnosis.
- Treatment at Schneider Children's Medical Center involved steroids and immunosuppressants, successfully controlling the disease.
- Doctors emphasize early diagnosis and treatment to prevent irreversible damage from morphea.
A 7-year-old girl, identified only as Noa, was initially told that the spots on her skin were sunspots and not a cause for concern. However, after years of the spots persisting and her seeking further medical opinions, she was finally diagnosed at age 18 with morphea, a rare chronic inflammatory disease. This condition causes hardening of the skin and can affect deeper tissues, including muscles and bones.
Noa's journey to diagnosis involved multiple consultations, with one doctor suggesting it might be a reaction to hair conditioner, leading her to wash her hair over the sink to avoid contact with her body. Eventually, the correct diagnosis of morphea was made, and she was referred to Schneider Children's Medical Center. There, she underwent a comprehensive medical evaluation and began treatment with intravenous steroids and an immunosuppressant medication.
The treatment proved successful in controlling the disease, rendering it inactive. While the spots on her back and abdomen remain, Noa no longer requires medication. Dr. Shiran Reiss-Hoss, a senior dermatologist at Schneider, emphasized that morphea is not merely an aesthetic issue, as it can lead to impaired growth in limbs, differences in length or circumference, restricted movement, and permanent deformities, especially in children.
Dr. Rotem Tal, a senior rheumatologist at Schneider, noted that the initial symptoms can resemble an old bruise, contributing to diagnostic delays. She explained that the condition can worsen over time, with months or even years passing between the first sign and a diagnosis. Diagnosis typically involves a physical examination, sometimes supplemented by a skin biopsy or imaging tests. Treatment varies based on severity, ranging from topical therapies or phototherapy for mild cases to systemic medication for deeper or more widespread involvement.
Doctors stress the importance of early diagnosis and appropriate treatment to prevent irreversible damage. They advise seeking medical attention for persistent skin spots, particularly if they enlarge, harden, change color, or become shiny, especially when located on limbs, the face, or the scalp. Despite the potential complications, most children with morphea lead full and active lives.